Dendreon, Novartis, and Stryker under Microscope

   Dendreon, Novartis, and Stryker under Microscope

Editor Note: For more information about this release, please scroll to bottom

PR Newswire

LONDON, July 17, 2013

LONDON, July 17, 2013 /PRNewswire/ --

On Tuesday, July 16, 2013, shares in healthcare companies ended mostly lower,
tracking losses in the broader market which slipped following a mixed batch of
economic and earnings reports. Investors also exercised caution ahead of Fed
Reserve Chairman Ben Bernanke's semi-annual testimony to Congress on
Wednesday. The major movers in the sector included Dendreon Corporation
(NASDAQ: DNDN), Novartis AG (ADR) (NYSE: NVS), and Stryker Corporation (NYSE:
SYK). has released full comprehensive research on DNDN,
NVS, and SYK. These free technical analyses can be downloaded by signing up

Shares in Dendreon Corporation fell sharply on Tuesday, as the broader market
struggled. The company's shares oscillated between $4.50 and $4.68 before
finishing the day 1.09% lower at $4.52. A total of 2.76 million shares were
traded which is below the daily average volume of 3.46 million. Despite
Tuesday's sharp decline, Dendreon's shares have gained 0.89% in the last five
trading sessions and 11.60% in the last one month. Nonetheless, in the last
three months, the stock has fallen by 0.22%. A free technical analysis on DNDN
available by signing up at:

Novartis AG's stock ended slightly lower on Tuesday, tracking losses in the
broader market. The company's shares ended the day 0.33% lower at $73.47 after
fluctuating between $73.27 and $73.64. A total of 1.07 million shares were
traded which is below the daily average volume of 1.47 million. Despite
Tuesday's pullback, the company's shares are currently trading near their
52-week high of $75.73. The stock has gained 1.14% in the last one month, but
has fallen by 0.24% in the past three months. Nonetheless, the stock is
currently trading above its 50-above and 200-day moving averages. Register
today and access free research on NVS at:

Shares in Stryker Corporation moved higher on Tuesday, extending their gains
from previous trading sessions. The company's shares ended the day 0.66%
higher at $68.67 after oscillating between $68.35 and $69.30. A total of 1.38
million shares were traded which is above the daily average volume of 1.18
million. The company's shares have gained 1.91% in the last three sessions,
2.17% in the last one month and 5.52% in the last three months. Furthermore,
the stock is currently trading near its 52-week high of $70.00. The free
report on SYK can be downloaded by signing up now at:


1.This is not company news. We are an independent source and our views do
    not reflect the companies mentioned.
2.Information in this release is fact checked and produced on a best efforts
    basis and reviewed by a CFA. However, we are only human and are prone to
    make mistakes. If you notice any errors or omissions, please notify us
3.This information is submitted as a net-positive to companies mentioned, to
    increase awareness for mentioned companies to our subscriber base and the
    investing public.
4.If you wish to have your company covered in more detail by our team, or
    wish to learn more about our services, please contact us at
5.For any urgent concerns or inquiries, please contact us at
6.Are you a public company? Would you like to see similar coverage on your
    company? Send us a full investors' package to for consideration.


Content is researched, written and reviewed on a best-effort basis. This
document, article or report is prepared and authored by Equity News Network.
An outsourced research services provider has, through Chartered Financial
Analysts, only reviewed the information provided by Equity News Network in
this article or report according to the Procedures outlined by Equity News
Network. Equity News Network is not entitled to veto or interfere in the
application of such procedures by the outsourced provider to the articles,
documents or reports, as the case may be.


Equity News Network makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or otherwise),
of the information provided in this document. This information is not to be
construed as personal financial advice. Readers are encouraged to consult
their personal financial advisor before making any decisions to buy, sell or
hold any securities mentioned herein.


Equity News Network is not responsible for any error which may be occasioned
at the time of printing of this document or any error, mistake or shortcoming.
No liability is accepted by Equity News Network whatsoever for any direct,
indirect or consequential loss arising from the use of this document. Equity
News Network expressly disclaims any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance placed on
the information in this document. Equity News Network does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the information. The
included information is subject to change without notice.

SOURCE AAA Research Reports

Contact: Phone #: +1-(646)-396-9126
Press spacebar to pause and continue. Press esc to stop.